Nicotine metabolism by the polymorphic cytochrome P450 2A6 (CYP2A6) enzyme: Implications for interindividual differences in smoking behaviour target article on nicotine-addiction

被引：0

作者：

Oscarson, M ^{[1
]}

机构：

[1] Karolinska Inst, Div Mol Toxicol, Natl Inst Environm Med, SE-17177 Stockholm, Sweden

来源：

PSYCOLOQUY | 2001年 / 12卷 / 03期

关键词：

nicotine; cytochrome P450; CYP2A6; drug metabolism; genetic polymorphism; genotype; phenotype;

D O I：

暂无

中图分类号：

B84 [心理学];

学科分类号：

04 ; 0402 ;

摘要：

Cytochrome P450 2A6 (CYP2A6) is one of the most important enzymes in human nicotine metabolism. Genetic polymorphisms in the CYP2A6 gene causes important interindividual variability in CYP2A6 activity and this variation can explain some of the interindividual variability in nicotine metabolism previously reported. Here I summarise the current knowledge about the CYP2A6 polymorphism, and also discuss the potential importance of this polymorphism for differences in smoking behaviour.

引用

页码：1 / 6

页数：6

共 50 条

[41] Human cytochrome P450 2A6 is the major enzyme involved in the metabolism of three alkoxyethers used as oxyfuels
Le Gal, A
Dréano, Y
Gervasi, PG
Berthou, F
TOXICOLOGY LETTERS, 2001, 124 (1-3) : 47 - 58
[42] Nicotine-related alkaloids and metabolites as inhibitors of human cytochrome P-450 2A6
Denton, TT
Zhang, XD
Cashman, JR
BIOCHEMICAL PHARMACOLOGY, 2004, 67 (04) : 751 - 756
[43] Synthetic Models Related to Methoxalen and Menthofuran-Cytochrome P450 (CYP) 2A6 Interactions. Benzofuran and Coumarin Derivatives as Potent and Selective Inhibitors of CYP2A6
Yamaguchi, Yuki
Akimoto, Ichie
Motegi, Kyoko
Yoshimura, Teruki
Wada, Keiji
Nishizono, Naozumi
Oda, Kazuaki
CHEMICAL & PHARMACEUTICAL BULLETIN, 2013, 61 (10) : 997 - 1001
[44] Cytochrome P450 2A6 whole-gene deletion (CYP2A6*4) polymorphism reduces risk of lung cancer: A meta-analysis
Johani, Fadzrul H.
Majid, Mohd S. A.
Azme, Muhammad H.
Nawi, Azmawati M.
TOBACCO INDUCED DISEASES, 2020, 18
[45] Point mutation of cytochrome P450 2A6 (a polymorphic variant CYP2A6.25) confers newsubstrate specificity towards flavonoids
Uno, Tomohide
Ogura, Chika
Izumi, Chiho
Nakamura, Masahiko
Yanase, Takeshi
Yamazaki, Hiroshi
Ashida, Hitoshi
Kanamaru, Kengo
Yamagata, Hiroshi
Imaishi, Hiromasa
BIOPHARMACEUTICS & DRUG DISPOSITION, 2015, 36 (08) : 552 - 563
[46] Cytochrome P450 2A6 and 2B6 polymorphisms and smoking cessation success in patients treated with varenicline
Paulo Roberto Xavier Tomaz
Mariana Soares Kajita
Juliana Rocha Santos
Jaqueline Scholz
Tânia Ogawa Abe
Patrícia Viviane Gaya
José Eduardo Krieger
Alexandre Costa Pereira
Paulo Caleb Júnior Lima Santos
European Journal of Clinical Pharmacology, 2019, 75 : 1541 - 1545
[47] CYP2A6*6, a novel polymorphism in cytochrome P450 2A6, has a single amino acid substitution (R128Q) that inactivates enzymatic activity
Kitagawa, K
Kunugita, N
Kitagawa, M
Kawamoto, T
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (21) : 17830 - 17835
[48] Cytochrome P450 2A6 and 2B6 polymorphisms and smoking cessation success in patients treated with varenicline
Xavier Tomaz, Paulo Roberto
Kajita, Mariana Soares
Santos, Juliana Rocha
Scholz, Jaqueline
Abe, Tania Ogawa
Gaya, Patricia Viviane
Krieger, Jose Eduardo
Pereira, Alexandre Costa
Junior Lima Santos, Paulo Caleb
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 75 (11) : 1541 - 1545
[49] Inhibition of cytochrome P450 2A6 (CYP2A6) decreases smoking and activation of the procarcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK).
Sellers, EM
Zeman, MV
Kaplan, HL
Tyndale, RF
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2000, 67 (02) : 113 - 113
[50] Cytochrome P450-Catalyzed Degradation of Nicotine: Fundamental Parameters Determining Hydroxylation by Cytochrome P450 2A6 at the 5′-Carbon or the N-Methyl Carbon
Kwiecien, Renata A.
Le Questel, Jean-Yves
Lebreton, Jacques
Delaforge, Marcel
Andre, Francois
Pihan, Emilie
Roussel, Anais
Fournial, Anais
Paneth, Piotr
Robins, Richard J.
JOURNAL OF PHYSICAL CHEMISTRY B, 2012, 116 (27): : 7827 - 7840

← 1 2 3 4 5 →